ROSIGLITAZONE SODIUM
UNII YR4MBO751R

Substance Identification & Data

This profile provides standardized clinical and technical data for Rosiglitazone Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YR4MBO751R.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 316371-83-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

YR4MBO751R

CAS Registry Number

316371-83-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ROSIGLITAZONE SODIUM

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H18N3O3S.Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XFOHHIYSRDUSCX-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C218276

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

23692351

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[N-]1C(SC(C1=O)Cc2ccc(cc2)OCCN(c3ncccc3)C)=O.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rosiglitazone Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.